ホーム › がん（全種類） › カリフォルニア州 › Baldwin Park
Baldwin Park、CAにおけるがん（全種類）の臨床試験
Baldwin Parkとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する34件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第3相
- City of Hope /ID# 243157, Duarte · 4マイル先
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第2/3相
- City of Hope National Medical Center /ID# 277005, Duarte · 4マイル先
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第2/3相
- City of Hope National Medical Center /ID# 282241, Duarte · 4マイル先
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
被験者募集中第1/2相
- City of Hope Duarte, Duarte · 4マイル先
A Study of ASP3082 in Adults With Advanced Solid Tumors
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
被験者募集中第2相
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte · 4マイル先
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
被験者募集中第1相
- City of Hope National Medical Center /ID# 280273, Duarte · 4マイル先
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
被験者募集中第1相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
被験者募集中第3相
- Quetzal Site 1, Duarte · 4マイル先
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
被験者募集中第3相
- City of Hope National Medical Center /ID# 281322, Duarte · 4マイル先
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- City Of Hope, Duarte · 4マイル先
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
被験者募集中第2相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
被験者募集中第3相
- Research Site, Duarte · 4マイル先
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
被験者募集中観察研究
- City of Hope, Duarte · 4マイル先
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
被験者募集中第1相
- City of Hope Duarte, Duarte · 4マイル先
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
被験者募集中第1/2相
- City of Hope National Medical Center /ID# 273132, Duarte · 4マイル先
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
被験者募集中第1/2相
- City of Hope - Duarte, Duarte · 4マイル先
Molecular Genetics Studies of Cancer Patients and Their Relatives
被験者募集中観察研究健康なボランティア歓迎
- City of Hope Medical Center, Duarte · 4マイル先
Childhood Cancer Survivor Study
被験者募集中観察研究健康なボランティア歓迎
- City of Hope National Medical Center, Duarte · 4マイル先
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
被験者募集中第1相
- The City of Hope National Medical Center, Duarte · 4マイル先
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
被験者募集中第2相
- City of Hope, Duarte · 4マイル先
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
被験者募集中
- Beckman Research Institute of City of Hope, Duarte · 4マイル先
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
被験者募集中第3相
- City of Hope, Duarte · 4マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Duarte · 4マイル先
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
被験者募集中観察研究
- City Of Hope, Duarte · 4マイル先
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
被験者募集中第3相
- City of Hope National Medical Center, Duarte · 4マイル先
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- New York City, NY109件の研究
- Boston, MA85件の研究
- Los Angeles, CA74件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Washington, DC58件の研究
- Durham, NC58件の研究
- Chicago, IL51件の研究
- Atlanta, GA49件の研究
- Seattle, WA49件の研究
- Arlington, VA48件の研究
Baldwin Parkにおける他の研究
- 乳がん44件の研究
- 急性骨髄性白血病40件の研究
- 大腸癌37件の研究
- 非小細胞肺癌36件の研究
- 前立腺がん30件の研究
- 転移性癌30件の研究
- 骨髄異形成症候群26件の研究
- 卵巣がん25件の研究
- 肺がん24件の研究
- 多発性骨髄腫23件の研究
- 胃癌22件の研究
- 急性リンパ性白血病21件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。